CXCL12 and bone cancer: CXCL12/CXCR4 signaling pathway activates sensitized neurons, astrocytes and microglia through mitogen-activated protein kinase (MAPK), promotes the release of inflammatory factors, such as IL(interleukin) and TNF, and causes persistent bone cancer pain (62).